GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clarity Pharmaceuticals Ltd (ASX:CU6) » Definitions » Inventories, Inventories Adjustments

Clarity Pharmaceuticals (ASX:CU6) Inventories, Inventories Adjustments : A$0.00 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Clarity Pharmaceuticals Inventories, Inventories Adjustments?

Clarity Pharmaceuticals's Inventories, Inventories Adjustments for the quarter that ended in Dec. 2023 was A$0.00 Mil.


Clarity Pharmaceuticals Inventories, Inventories Adjustments Historical Data

The historical data trend for Clarity Pharmaceuticals's Inventories, Inventories Adjustments can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clarity Pharmaceuticals Inventories, Inventories Adjustments Chart

Clarity Pharmaceuticals Annual Data
Trend Jun22 Jun23
Inventories, Inventories Adjustments
- -

Clarity Pharmaceuticals Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Inventories, Inventories Adjustments Get a 7-Day Free Trial - - - - -

Clarity Pharmaceuticals Inventories, Inventories Adjustments Calculation

Inventories, Inventories Adjustments represents certain charges made in the current period in inventory resulting from breakage, spoilage, employee theft and shoplifting, etc.


Clarity Pharmaceuticals (ASX:CU6) Business Description

Industry
Traded in Other Exchanges
Address
4 Cornwallis Street, National Innovation Centre, Eveleigh, Sydney, NSW, AUS, 2015
Clarity Pharmaceuticals Ltd is a clinical-stage radiopharmaceutical company developing next-generation theranostic (therapy and imaging) products, based on its platform SAR Technology. The SAR technology is ideally suited for use with copper isotopes, enabling superior imaging and therapeutic characteristics of radiopharmaceutical products and addressing the current manufacturing and logistical limitations in the growth of the radiopharmaceutical sector in oncology.

Clarity Pharmaceuticals (ASX:CU6) Headlines

No Headlines